BlackRock Investment Management’s ChemoCentryx, Inc. CCXI Stock Holding History

BlackRock Investment Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$681K	Buy	92,004 +1,265	+1%	+$9.11K	﹤0.01%	2912
2016 Q3	$548K	Buy	90,739 +35	+0%	+$165	﹤0.01%	3004
2016 Q2	$407K	Sell	90,704 -9,208	-9%	-$34.6K	﹤0.01%	3150
2016 Q1	$249K	Buy	99,912 +1,818	+2%	+$6.62K	﹤0.01%	3118
2015 Q4	$795K	Buy	98,094 +216	+0.2%	+$1.53K	﹤0.01%	2753
2015 Q3	$592K	Sell	97,878 -2,393	-2%	-$17.3K	﹤0.01%	2947
2015 Q2	$825K	Buy	100,271 +9,464	+10%	+$75.2K	﹤0.01%	2909
2015 Q1	$686K	Sell	90,807 -637	-0.7%	-$4.98K	﹤0.01%	2790
2014 Q4	$625K	Buy	91,444 +509	+0.6%	+$2.69K	﹤0.01%	2872
2014 Q3	$409K	Buy	90,935 +3,233	+4%	+$17.1K	﹤0.01%	3079
2014 Q2	$513K	Buy	87,702 +18,803	+27%	+$106K	﹤0.01%	3029
2014 Q1	$457K	Buy	68,899 +824	+1%	+$5.73K	﹤0.01%	2999
2013 Q4	$394K	Sell	68,075 -433	-0.6%	-$2.23K	﹤0.01%	3066
2013 Q3	$381K	Buy	68,508 +5,856	+9%	+$63.3K	﹤0.01%	3037
2013 Q2	$886K	Buy	+62,652	New	+$812K	﹤0.01%	2457

Other funds holding CCXI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Investment Management's CCXI Position: Q4 2016 in Review

BlackRock Investment Management increased its ChemoCentryx, Inc. (CCXI) stake by 1.4% in Q4 2016, buying an estimated $9.11K and bringing the position to 92,004 shares worth $681K. The position accounts for ﹤0.01% of the portfolio, ranked #2912.

BlackRock Investment Management first reported a position in CCXI in Q2 2013 and has held it in 15 quarters since. The position peaked at $886K in Q2 2013. 89 funds tracked by Wall St. Rank hold CCXI as of Q4 2016.

BlackRock Investment Management held 92,004 shares of ChemoCentryx, Inc. worth $681K as of Q4 2016.
BlackRock Investment Management bought 1,265 ChemoCentryx, Inc. shares in Q4 2016, an estimated $9.11K.
ChemoCentryx, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2912 holding.
BlackRock Investment Management first reported a position in ChemoCentryx, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's ChemoCentryx, Inc. position peaked at $886K in Q2 2013.
89 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.